BFNH
BIOFORCE NANOSCIENCES HOLDINGS, INC.Company Information
- Company Name
- BIOFORCE NANOSCIENCES HOLDINGS, INC.
- CIK
- CIK0001310488
- Category
- <br>Emerging growth company
- Ticker: Exchange
- BFNH: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3826
- SIC Description
- Laboratory Analytical Instruments
- Ticker
- BFNH
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-04-22
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 26,700,000
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-10
- Price on filing date
- —
- 1-month reaction
- 173.54%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | 2 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Assets | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Accrued Salaries Current And Noncurrent | 0 | 1 | 1 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 1 | ||||||
| Liabilities Current | 0 | 1 | 1 | 1 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Liabilities | 0 | 1 | 1 | 1 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Stockholders Equity | 2 | -1 | -1 | -0 | -0 | -0 | -2 | -2 | -2 | -2 | -2 | -2 | ||||||
| Additional Paid In Capital Common Stock | 162 | 162 | 162 | 162 | 162 | 162 | 159 | 159 | 159 | 159 | 159 | 159 | ||||||
| Retained Earnings Accumulated Deficit | -162 | -163 | -162 | -162 | -162 | -162 | -161 | -161 | -161 | -161 | -161 | -161 | ||||||
| Liabilities And Stockholders Equity | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | 0.00 | - | - | - | 0.00 | - | - | - | - | - | ||||||
| Preferred Stock Shares Authorized | - | - | 100 | - | - | - | 100 | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | ||||||
| Common Stock Shares Issued | 34 | 34 | 34 | 34 | 34 | 34 | 29 | 29 | 29 | 29 | 29 | 29 | ||||||
| Shares Outstanding | 34 | 34 | 34 | 34 | 34 | 34 | 29 | 29 | 29 | 29 | 29 | 29 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) — SEC Financial Statements & Analysis
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) is a laboratory analytical instruments company. BIOFORCE NANOSCIENCES HOLDINGS, INC. trades on OTC as: BFNH. BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10. Based on that filing, BIOFORCE NANOSCIENCES HOLDINGS, INC. carries a market cap of $55.35M, a P/E ratio of -568.01x, a P/B ratio of 24.03x, an enterprise value of $55.35M, and an EV/EBITDA multiple of -568.01x. On profitability, it posts a Return on Equity (ROE) of -10.15%, a Return on Assets (ROA) of -8.16%, and a Return on Invested Capital (ROIC) of -10.16%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -92.52% year-over-year and EPS growth of -92.53% year-over-year. On the balance sheet, it maintains a current ratio of 25.41x, a quick ratio of 0.00x, working capital of $2.07M, a debt-to-equity ratio of 0.04x, a debt ratio of 0.04, free cash flow of $-41.93K (TTM), and net debt of $-307. Figures sourced from SEC EDGAR.
- Market Cap
- $55.35M
- P/E TTM
- -568.01x
- EPS TTM
- $-0.00
- P/B TTM
- 24.03x
- ROE TTM
- -10.15%
- ROA TTM
- -8.16%
- Debt To Equity
- 0.04x
- Free Cash Flow TTM
- $-41.93K
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BIOFORCE NANOSCIENCES HOLDINGS, INC. in?
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) operates in the Laboratory Analytical Instruments industry.
What exchange does BFNH trade on?
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) trades on the OTC.
When was BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)'s most recent SEC filing?
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10.
What is BFNH's market cap?
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) has a market capitalization of $55.35M as of 2026-06-30.
What is BFNH's EPS (earnings per share)?
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)'s trailing twelve month EPS is $-0.00 as of 2026-06-30.
What is BFNH's ROE (return on equity)?
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)'s trailing twelve month Return on Equity (ROE) is -10.15% as of 2026-06-30.
What is BFNH's ROA (return on assets)?
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)'s trailing twelve month Return on Assets (ROA) is -8.16% as of 2026-06-30.
What is BFNH's ROIC (return on invested capital)?
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)'s trailing twelve month Return on Invested Capital (ROIC) is -10.16% as of 2026-06-30.
What is BFNH's EV/EBITDA?
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)'s trailing twelve month EV/EBITDA is -568.01x as of 2026-06-30.